ResMed Inc.

RMD

Financial Statements

Income Statement (Annual)

Amounts in millions

2025

6/30/2025

Revenue

5,146

Cost of Revenue

2,091

Gross Profit

3,055

Gross Margin

59.4%

Operating Income

1,685

Operating Margin

32.7%

Net Income

1,401

Net Margin

27.2%

EPS (Basic)

$9.55

EPS (Diluted)

$9.51

EBITDA

1,913

EBITDA Margin

37.2%

2024

6/30/2024

Revenue

4,685

Cost of Revenue

2,030

Gross Profit

2,655

Gross Margin

56.7%

Operating Income

1,320

Operating Margin

28.2%

Net Income

1,021

Net Margin

21.8%

EPS (Basic)

$6.94

EPS (Diluted)

$6.92

EBITDA

1,534

EBITDA Margin

32.7%

2023

6/30/2023

Revenue

4,223

Cost of Revenue

1,867

Gross Profit

2,356

Gross Margin

55.8%

Operating Income

1,132

Operating Margin

26.8%

Net Income

898

Net Margin

21.3%

EPS (Basic)

$6.12

EPS (Diluted)

$6.09

EBITDA

1,359

EBITDA Margin

32.2%

2022

6/30/2022

Revenue

3,578

Cost of Revenue

1,554

Gross Profit

2,024

Gross Margin

56.6%

Operating Income

1,000

Operating Margin

28.0%

Net Income

779

Net Margin

21.8%

EPS (Basic)

$5.34

EPS (Diluted)

$5.30

EBITDA

1,177

EBITDA Margin

32.9%

2021

6/30/2021

Revenue

3,197

Cost of Revenue

1,358

Gross Profit

1,839

Gross Margin

57.5%

Operating Income

904

Operating Margin

28.3%

Net Income

475

Net Margin

14.8%

EPS (Basic)

$3.27

EPS (Diluted)

$3.24

EBITDA

1,104

EBITDA Margin

34.5%

Income Statement (Annual)

Financial performance (amounts in millions)

Item	2025	2024	2023	2022	2021
Revenue	5,146	4,685	4,223	3,578	3,197
Cost of Revenue	2,091	2,030	1,867	1,554	1,358
Gross Profit	3,055	2,655	2,356	2,024	1,839
Gross Margin	59.4%	56.7%	55.8%	56.6%	57.5%
Operating Income	1,685	1,320	1,132	1,000	904
Operating Margin	32.7%	28.2%	26.8%	28.0%	28.3%
Net Income	1,401	1,021	898	779	475
Net Margin	27.2%	21.8%	21.3%	21.8%	14.8%
EPS (Basic)	$9.55	$6.94	$6.12	$5.34	$3.27
EPS (Diluted)	$9.51	$6.92	$6.09	$5.30	$3.24
EBITDA	1,913	1,534	1,359	1,177	1,104
EBITDA Margin	37.2%	32.7%	32.2%	32.9%	34.5%